This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Quinoline
- DrugBank Accession Number
- DB18050
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Quinoline (DB18050)
- Weight
- Average: 129.162
Monoisotopic: 129.057849229 - Chemical Formula
- C9H7N
- Synonyms
- 1-azanaphthalene
- 1-benzazine
- 2,3-benzopyridine
- Benzo(b)pyridine
- Chinoleine
- Leucol
- Leukol
- External IDs
- FEMA NO. 3470
- NSC-3396
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- E66400VT9R
- CAS number
- 91-22-5
- InChI Key
- SMWDFEZZVXVKRB-UHFFFAOYSA-N
- InChI
- InChI=1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H
- IUPAC Name
- quinoline
- SMILES
- C1=CC2=CC=CN=C2C=C1
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0033731
- KEGG Compound
- C06413
- ChemSpider
- 6780
- BindingDB
- 50047015
- ChEBI
- 17362
- ChEMBL
- CHEMBL14474
- ZINC
- ZINC000000896153
- Wikipedia
- Quinoline
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Recruiting Treatment Shock, Hypovolemic 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 2.13 Chemaxon pKa (Strongest Basic) 4.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 12.89 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 39.98 m3·mol-1 Chemaxon Polarizability 13.95 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 08, 2023 20:05 / Updated at September 12, 2023 18:33